RIFAMPICIN IMPREGNATION OF A PROTEIN-SEALED DACRON GRAFT - AN INFECTION-RESISTANT PROSTHETIC VASCULAR GRAFT

被引:32
作者
AVRAMOVIC, JR [1 ]
FLETCHER, JP [1 ]
机构
[1] WESTMEAD HOSP,DEPT SURG,WESTMEAD,NSW 2145,AUSTRALIA
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1991年 / 61卷 / 06期
关键词
GELATIN-SEALED DACRON; INFECTION; PROSTHETIC VASCULAR GRAFT; RIFAMPICIN; STAPHYLOCOCCUS-AUREUS;
D O I
10.1111/j.1445-2197.1991.tb00258.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
A gelatin-sealed knitted Dacron vascular graft was prepared by passive impregnation with rifampicin and implanted in the common carotid artery of 10 merino sheep. Another 10 merino sheep had an untreated graft inserted. The graft was topically inoculated with 1 mL of 10(8) colony forming units per mL of Staphylococcus aureus before wound closure. The grafts were harvested at 3 weeks and cultured. All untreated grafts and surrounding tissues became infected. One of the 10 grafts treated with rifampicin became infected (P = 0.0002) and 4 sheep with rifampicin-treated grafts had surrounding tissue infection. No bacteria cultured from the rifampicin-treated sheep developed resistance to rifampicin.
引用
收藏
页码:436 / 440
页数:5
相关论文
共 18 条
[1]  
McDougal E.G., Burnham S.J., Johnson G., Rifampicin protection against experimental graft sepsis, J. Vasc. Surg., 4, pp. 5-7, (1986)
[2]  
Moore W.S., Chvapil M., Seiffert G., Keown K., Development of an infection‐resistant vascular prosthesis, Arch. Surg., 116, pp. 1403-1407, (1981)
[3]  
Shue W.B., Worosilo S.C., Donetz A.P., Trooskin S.Z., Harvey R.A., Creco R.S., Prevention of vascular prosthetic infection with an antibiotic‐bonded Dacron graft, J. Vusc. Surg., 8, pp. 600-605, (1988)
[4]  
Clark R.E., Magraf H.W., Antibacterial vascular grafts with improved thrombo resistance, Arch. Surg., 109, pp. 150-162, (1974)
[5]  
Krag L.E., Solheim K., Antibiotic binding polytevafluoroethylene via glucosaminoglycan‐keratin luminal coating, Surgery, 100, pp. 629-634, (1986)
[6]  
Kempczinski R.F., Discussion following Moore et al. Development of an infection‐resistant vascular prosthesis. Discussion at the 29th Scientific Meeting of the International Cardiovascular Society, North Amer. Chapter, Dallas, Arch. Surg., 116, (1981)
[7]  
Powell T.W., Burnham S.J., Johnson G., A passive system using Rifampicin to create an infection‐resistant vascular prosthesis, Surgery, 94, pp. 765-769, (1983)
[8]  
Ashton T.R., Cummingham J.D., Paton D., Maini R., (1990)
[9]  
Cruickshank R., Duguid J.P., Marmion B.P., Swain R.H.A., Medical Microbiology, (1975)
[10]  
Bunt T.J., Synthetic vascular graft infections. I. Graft Infections, Surgery, 93, pp. 733-746, (1983)